The CKLF1‐C19 peptide attenuates allergic lung inflammation by inhibiting CCR3‐ and CCR4‐mediated chemotaxis in a mouse model of asthma

To cite this article: Tian L, Li W, Wang J, Zhang Y, Zheng Y, Qi H, Guo X, Zhang Y, Ma D, Shen H, Wang Y. The CKLF1‐C19 peptide attenuates allergic lung inflammation by inhibiting CCR3‐ and CCR4‐mediated chemotaxis in a mouse model of asthma. Allergy 2011; 66: 287–297.

[1]  Dan Li,et al.  Two C-terminal peptides of human CKLF1 interact with the chemokine receptor CCR4. , 2008, The international journal of biochemistry & cell biology.

[2]  Yong Chul Lee,et al.  Inhibition of phosphoinositide 3‐kinase δ attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  W. Han,et al.  Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4) , 2005, Life Sciences.

[4]  P. Schmid‐Grendelmeier,et al.  Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective , 2005, Current opinion in pulmonary medicine.

[5]  E. Lenkiewicz,et al.  Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.

[6]  G. Zeng,et al.  Chemokine-like factor 1, a novel cytokine, contributes to airway damage, remodeling and pulmonary fibrosis. , 2004, Chinese medical journal.

[7]  S. Kunkel,et al.  Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4‐/‐ mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  R. Geha,et al.  CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. , 2002, The Journal of clinical investigation.

[9]  D. Friend,et al.  The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Hogaboam,et al.  CXCR2 Is Necessary for the Development and Persistence of Chronic Fungal Asthma in Mice1 , 2002, The Journal of Immunology.

[11]  C. Hogaboam,et al.  The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice1 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  E. Israel,et al.  Variant eotaxin: its effects on the asthma phenotype. , 2001, The Journal of allergy and clinical immunology.

[13]  T. Moore,et al.  Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling1 , 2001, The Journal of Immunology.

[14]  S. Lira,et al.  Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation , 2001, The Journal of experimental medicine.

[15]  M. Burdick,et al.  Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. , 2001, The Journal of clinical investigation.

[16]  L. Wang,et al.  Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity. , 2001, The Biochemical journal.

[17]  E. Israel,et al.  Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. , 2001, American journal of respiratory and critical care medicine.

[18]  Tong-Yuan Yang,et al.  Aberrant in Vivo T Helper Type 2 Cell Response and Impaired Eosinophil Recruitment in Cc Chemokine Receptor 8 Knockout Mice , 2001, The Journal of experimental medicine.

[19]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[20]  E. Israel,et al.  Eotaxin and impaired lung function in asthma. , 1999, American journal of respiratory and critical care medicine.

[21]  T. Nishi,et al.  A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. , 1999, Journal of immunology.

[22]  R. Homer,et al.  Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. , 1999, Journal of immunology.

[23]  H. Meurs,et al.  Involvement of tachykinin NK1 receptor in the development of allergen-induced airway hyperreactivity and airway inflammation in conscious, unrestrained guinea pigs. , 1998, American journal of respiratory and critical care medicine.

[24]  K. Matsushima,et al.  Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. , 1999, International immunology.

[25]  A. Bellini,et al.  Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation , 1998, Clinical and experimental immunology.

[26]  P. Gray,et al.  Macrophage-derived Chemokine Is a Functional Ligand for the CC Chemokine Receptor 4* , 1998, The Journal of Biological Chemistry.

[27]  S. Phan,et al.  The role of eosinophils in pulmonary fibrosis (Review). , 1998, International journal of molecular medicine.

[28]  R. Homer,et al.  Induction of Airway Mucus Production By T Helper 2 (Th2) Cells: A Critical Role For Interleukin 4 In Cell Recruitment But Not Mucus Production , 1997, The Journal of experimental medicine.

[29]  E. Gelfand,et al.  Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. , 1997, American journal of respiratory and critical care medicine.

[30]  M. Baggiolini,et al.  Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes , 1997, The Journal of experimental medicine.

[31]  O. Yoshie,et al.  The T Cell-directed CC Chemokine TARC Is a Highly Specific Biological Ligand for CC Chemokine Receptor 4* , 1997, The Journal of Biological Chemistry.

[32]  M. Jordana,et al.  Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. , 1996, American journal of respiratory and critical care medicine.

[33]  B. Schmekel,et al.  Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: a controlled study. , 1996, Thorax.

[34]  C. Mackay,et al.  Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils , 1996, The Journal of experimental medicine.

[35]  J. Demartino,et al.  Cloning, expression, and characterization of the human eosinophil eotaxin receptor , 1996, The Journal of experimental medicine.

[36]  T. W. van der Mark,et al.  A novel method to assess airway function parameters in chronically instrumented, unrestrained guinea-pigs. , 1992, Pulmonary pharmacology.